Mistletoe Therapy UK
- making a difference together -

Read more          VIEW OUR CENTRES

Update: Two safety studies published

Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer : Thronicke et al 2017
This study looks at adverse reactions in patients receiving immune therapy and those receiving immune therapy alongside mistletoe therapy. It suggests that there is no significant difference in adverse reactions in the two groups.


Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients : Schad et al 2017
This study explores adverse reactions to low and high dose mistletoe therapy during the introduction phase. It indicates that although high dose introduction is associated with more adverse reactions, nearly all such reactions were expected , of mild to moderate intensity and most were desired reactions.


To read more about either study, visit our Research page.


Mistletoe Trial given go ahead

We are very pleased to announce that a pilot randomised controlled trial with
mistletoe therapy for breast cancer in the UK
has been given the go ahead.
Find our more by visiting our campaign page.

We ask you to take this unique opportunity to show your support.

Donate Now!


Information, research and support

This website has been set up at the request of patients and their families. It offers information about mistletoe therapy for cancer care, where it can be accessed in the UK and relevant research.

Test Patient logo

Our Aims

Read about the aims of the Mistletoe Therapy UK.

For Public

Patient Stories

Listen to patients talk about their experience of the Mistletoe Therapy UK.

For professionals


Find out more about mistletoe research.

New fundraising packs now available

Help raise money for Mistletoe Therapy UK and have fun along the way!

Request a free e-fundraising pack today!

Request a pack

Pack fan